Janney Montgomery Scott LLC Dexcom Inc Transaction History

Janney Montgomery Scott LLC

$38.3 Billion
Q2 2025

A detailed history of Janney Montgomery Scott LLC transactions in Dexcom Inc stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 43,067 shares of DXCM stock, worth $3.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

43,067

Previous 238,424 81.94%

Holding current value

$3.45 Million

Previous $16.3 Million 76.91%

% of portfolio

0.01%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$59.83 - $87.57 $11.7 Million - $17.1 Million	-195,357 Reduced 81.94%	43,067 $3.76 Million
Q1 2025 Apr 17, 2025	BUY	$67.74 - $90.75 $398,378 - $533,700	5,881 Added 2.53%	238,424 $16.3 Million
Q4 2024 Jan 17, 2025	BUY	$65.68 - $81.01 $14.6 Million - $18 Million	222,548 Added 2226.59%	232,543 $18.1 Million
Q3 2024 Oct 29, 2024	SELL	$64.0 - $116.06 $835,840 - $1.52 Million	-13,060 Reduced 56.65%	9,995 $670,000
Q2 2024 Jul 25, 2024	SELL	$110.31 - $140.45 $640,239 - $815,171	-5,804 Reduced 20.11%	23,055 $2.61 Million
Q1 2024 May 01, 2024	SELL	$114.22 - $140.1 $344,030 - $421,981	-3,012 Reduced 9.45%	28,859 $4 Million
Q4 2023 Feb 07, 2024	SELL	$75.49 - $124.16 $324,154 - $533,143	-4,294 Reduced 11.87%	31,871 $3.95 Million
Q3 2023 Nov 08, 2023	SELL	$86.06 - $137.93 $1.85 Million - $2.97 Million	-21,505 Reduced 37.29%	36,165 $3.37 Million
Q2 2023 Jul 26, 2023	BUY	$112.47 - $130.98 $1.47 Million - $1.71 Million	13,061 Added 29.28%	57,670 $7.41 Million
Q1 2023 Apr 28, 2023	SELL	$104.0 - $122.92 $128,232 - $151,560	-1,233 Reduced 2.69%	44,609 $5.18 Million
Q4 2022 Feb 01, 2023	BUY	$84.98 - $122.67 $900,533 - $1.3 Million	10,597 Added 30.07%	45,842 $5.19 Million
Q3 2022 Oct 25, 2022	SELL	$76.35 - $94.18 $70,776 - $87,304	-927 Reduced 2.56%	35,245 $2.84 Million
Q2 2022 Aug 03, 2022	BUY	$67.99 - $132.89 $1.89 Million - $3.7 Million	27,806 Added 332.37%	36,172 $2.7 Million
Q1 2022 May 04, 2022	BUY	$94.08 - $130.2 $71,218 - $98,561	757 Added 9.95%	8,366 $4.28 Million
Q4 2021 Jan 27, 2022	BUY	$129.87 - $162.82 $45,194 - $56,661	348 Added 4.79%	7,609 $4.09 Million
Q3 2021 Oct 29, 2021	BUY	$106.71 - $143.18 $40,763 - $54,694	382 Added 5.55%	7,261 $3.97 Million
Q2 2021 Jul 26, 2021	BUY	$80.99 - $107.93 $335,217 - $446,722	4,139 Added 151.06%	6,879 $2.94 Million
Q1 2021 Apr 27, 2021	SELL	$84.79 - $104.74 $205,700 - $254,099	-2,426 Reduced 46.96%	2,740 $985,000
Q4 2020 Jan 25, 2021	SELL	$78.0 - $104.5 $994,422 - $1.33 Million	-12,749 Reduced 71.16%	5,166 $1.91 Million
Q3 2020 Nov 06, 2020	SELL	$95.51 - $112.95 $80,132 - $94,765	-839 Reduced 4.47%	17,915 $7.39 Million
Q2 2020 Jul 23, 2020	BUY	$62.68 - $105.34 $649,678 - $1.09 Million	10,365 Added 123.55%	18,754 $7.6 Million
Q1 2020 Apr 30, 2020	SELL	$47.79 - $75.63 $142,557 - $225,604	-2,983 Reduced 26.23%	8,389 $2.26 Million
Q4 2019 Jan 21, 2020	SELL	$36.62 - $57.29 $12,890 - $20,166	-352 Reduced 3.0%	11,372 $2.49 Million
Q3 2019 Oct 29, 2019	SELL	$35.53 - $43.8 $22,597 - $27,856	-636 Reduced 5.15%	11,724 $1.75 Million
Q2 2019 Jul 29, 2019	BUY	$27.84 - $38.92 $65,618 - $91,734	2,357 Added 23.56%	12,360 $1.85 Million
Q1 2019 Apr 30, 2019	BUY	$28.07 - $38.18 $118,455 - $161,119	4,220 Added 72.97%	10,003 $1.19 Million
Q4 2018 Feb 01, 2019	BUY	$26.99 - $37.37 $39,702 - $54,971	1,471 Added 34.11%	5,783 $693,000
Q3 2018 Nov 05, 2018	SELL	$23.35 - $36.72 $1,004 - $1,578	-43 Reduced 0.99%	4,312 $617,000
Q2 2018 Jul 24, 2018	SELL	$17.54 - $25.22 $8,682 - $12,483	-495 Reduced 10.21%	4,355 $414,000
Q1 2018 Apr 19, 2018	BUY	$13.06 - $18.54 $5,224 - $7,416	400 Added 8.99%	4,850 $360,000
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $49,484 - $68,441	4,450	4,450 $255,000

Others Institutions Holding DXCM

# of Institutions

1,107

Shares Held

370M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Dexcom Inc Transaction History